Clinical Trial Update: S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 immunosuppressive therapy trial for myelodysplastic syndrome (with leukemia as a listed condition).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED